Surmodics | SRDX - Market Capitalization


Surmodics reported $393.5M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
Anika Therapeutics USD 210M 71M Mar/2026
Arrowhead Research USD 9.02B 4.25B Dec/2025
Artivion USD 1.57B 616M Mar/2026
Baxter International USD 9.82B 1.87B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
EDAP TMS EUR 138M 65M Mar/2026
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Haemonetics USD 3.76B 1.44B Dec/2025
Heron Therapeutics USD 133M 105M Mar/2026
J&J USD 500.24B 67.44B Dec/2025
Merit Medical Systems USD 5.23B 297M Dec/2025
Option Care Health USD 5.06B 552M Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Trinity Biotech USD 5M 8M Mar/2026